Here's a Long Answer Question (LAQ) on Retinoblastoma, structured with a clinical case

and integrated content from Parsons, Kanski, and Khurana — perfect for MBBS/professional
exams:

Clinical Case:
A 2-year-old child is brought by parents with complaints of a white reflex in the right eye noticed
in photographs for the past 2 months. There is no history of trauma. On examination, the child is
found to have leukocoria, strabismus, and a yellowish-white mass seen in the fundus. No
family history of similar illness is reported.

Q: Discuss Retinoblastoma under the following headings:

1. Definition

●​ Retinoblastoma is the most common primary intraocular malignancy of childhood,

arising from immature retinal cells (retinoblasts).
●​ It may be heritable (40%) or non-heritable/sporadic (60%).
●​ Median age of presentation: 18 months (bilateral); 24 months (unilateral).

2. Etiopathogenesis (Parsons, Khurana)

●​ Caused by mutations in the RB1 gene on chromosome 13q14, a tumor suppressor

gene.
●​ Follows the two-hit hypothesis (Knudson):
○​ Heritable cases: First hit is germline, second is somatic.
○​ Sporadic cases: Both hits are somatic.
●​ May be:
○​ Unilateral (60%) – usually sporadic.
○​ Bilateral (40%) – usually hereditary.

3. Clinical Features (Parsons, Kanski)

Symptoms:
 ●​ Leukocoria (most common; “cat’s eye reflex”)
●​ Strabismus (second most common)
●​ Decreased vision
●​ Pain, redness (if secondary glaucoma/inflammation)
●​ Proptosis (in advanced extraocular disease)

Signs:

●​ Leukocoria on fundus photography or red reflex test

●​ Fundus: creamy white vascular mass
●​ Endophytic or exophytic growth patterns
●​ Calcification seen on imaging (CT)

4. Classification (Kanski, Khurana)

International Classification of Intraocular Retinoblastoma (ICIR):

●​ Group A to E, based on tumor size, location, seeding, and risk of globe salvage.

Reese-Ellsworth Classification (older) – used for prognosis after radiotherapy.

5. Investigations

●​ Fundus examination under anesthesia (EUA)

●​ Ultrasound B-scan: Shows intraocular mass with calcification
●​ CT scan (if needed): Calcification
●​ MRI orbit and brain: Preferred for optic nerve involvement, trilateral retinoblastoma
(pineal gland tumor)
●​ Genetic testing: For RB1 mutations, especially in bilateral/familial cases

6. Differential Diagnosis (Leukocoria D/Ds):

●​ Coats disease
●​ Congenital cataract
●​ Toxocariasis
●​ Persistent fetal vasculature (PHPV)
●​ Retinopathy of prematurity (ROP)
7. Management (Parsons, Kanski, Khurana)

Goals:

●​ Life → Eye → Vision preservation

Treatment options:

1. Conservative (Globe Salvaging)

●​ Focal therapies:
○​ Laser photocoagulation
○​ Cryotherapy
○​ Thermotherapy
●​ Systemic chemotherapy (chemoreduction):
○​ Vincristine, Etoposide, Carboplatin
●​ Intra-arterial chemotherapy (IAC):
○​ Melphalan via ophthalmic artery
●​ Intravitreal chemotherapy for vitreous seeds

2. Enucleation:

●​ Indicated in advanced, unilateral cases (Group E)

●​ Optic nerve cut with margin
●​ Orbital implant may be placed

3. Radiotherapy:

●​ Reserved for refractory/residual cases

●​ External beam radiation therapy (EBRT) — used sparingly due to risk of second
malignancies

8. Prognosis (Kanski)

●​ Survival rate: > 95% in developed countries with early detection.

●​ Worse prognosis if:
○​ Optic nerve invasion
○​ Extraocular spread
○​ Delayed diagnosis

9. Follow-Up
 ●​ Lifelong follow-up needed in hereditary cases due to risk of:
○​ Second primary tumors (osteosarcoma, soft tissue sarcomas)
○​ Trilateral retinoblastoma
●​ Siblings should be screened if hereditary.

Conclusion:
Retinoblastoma is a pediatric ocular emergency. Early diagnosis, appropriate use of imaging
and classification systems, and multimodal therapy can save life, eye, and vision. Genetic
counseling is crucial in familial cases.

Here's a detailed explanation of the Classification and Investigations of Retinoblastoma,

with references integrated from Parsons, Kanski, and Khurana — exam-ready and
concept-focused:

🔷 CLASSIFICATION OF RETINOBLASTOMA
Classification is essential to guide treatment decisions and prognosis. Two main systems are
used:

✅ 1. International Classification of Intraocular Retinoblastoma (ICIR)

(Kanski, Khurana)

Used to predict the likelihood of globe salvage with chemotherapy and focal therapy

Group A – Very low risk

●​ Tumors ≤ 3 mm in size
●​ Located >3 mm from foveola and >1.5 mm from optic disc
●​ No subretinal or vitreous seeding

Group B – Low risk

●​ Tumors > 3 mm or closer to foveola/optic disc

●​ No subretinal/vitreous seeding
 ●​ May have subretinal fluid <3 mm from tumor

Group C – Moderate risk

●​ Localized vitreous or subretinal seeding (<3 mm from tumor)

●​ Focal subretinal fluid, limited extent

Group D – High risk

●​ Diffuse subretinal or vitreous seeding

●​ Massive tumor
●​ Subretinal fluid > one quadrant

Group E – Very high risk (poor prognosis for eye salvage)

●​ Tumors involving >50% globe

●​ Neovascular glaucoma
●​ Hyphema or vitreous hemorrhage
●​ Tumor touching lens
●​ Phthisis bulbi

✅ 2. Reese-Ellsworth Classification (Older system – Parsons)

**Used historically to predict outcome following external beam radiotherapy (EBRT)

Group I – Very favorable

●​ Solitary tumor < 4 DD at or behind equator

●​ Multiple tumors none >4 DD behind equator

Group II – Favorable

●​ Solitary tumor 4–10 DD behind equator

●​ Multiple tumors 4–10 DD behind equator

Group III – Doubtful

●​ Any tumor anterior to equator

●​ Solitary tumor >10 DD behind equator

Group IV – Unfavorable

●​ Multiple tumors, some >10 DD

●​ Tumors crossing equator
Group V – Very unfavorable

●​ Massive tumors involving more than half the retina

●​ Vitreous seeding

(DD = Disc Diameter ≈ 1.5 mm)

🔷 INVESTIGATIONS IN RETINOBLASTOMA
Thorough evaluation is necessary to confirm diagnosis, assess extent, and plan treatment.

✅ 1. Clinical Examination
●​ Leukocoria detection (white pupillary reflex)
●​ Strabismus
●​ Fundus Examination under Anesthesia (EUA) – to directly visualize tumor, seeds, and
assess extent

✅ 2. Imaging Studies
🔸 A. B-Scan Ultrasonography
(Parsons, Khurana)

●​ Shows intraocular mass with:

○​ High internal reflectivity
○​ Calcification (highly suggestive)
●​ Useful for opaque media (e.g., cataract, hemorrhage)

🔸 B. MRI of Brain and Orbits

(Preferred over CT)

●​ No radiation (especially in hereditary cases)

●​ Best for:
○​ Optic nerve involvement
○​ Extraocular extension
○​ Trilateral retinoblastoma (pineoblastoma)

🔸 C. CT Scan (Non-contrast)
 ●​ Detects calcification (pathognomonic)
●​ Used if MRI is unavailable
●​ Avoid in hereditary cases due to radiation exposure

✅ 3. Ancillary Tests
🔹 Genetic Testing
●​ RB1 gene mutation analysis:
○​ Important in bilateral cases
○​ Also for family screening and counseling
○​ Helps in predicting risk of second primary tumors

🔹 Fine Needle Aspiration Biopsy (FNAB)

●​ Contraindicated due to risk of tumor dissemination

✅ 4. Other Investigations
●​ Lumbar Puncture & Bone Marrow Aspiration:​

○​ Only in extraocular spread or high-risk features

●​ Complete blood count, renal function, LFTs​

○​ For chemotherapy planning

✅ Screening for Trilateral Retinoblastoma

In hereditary cases → MRI of brain to detect pinealoblastoma or suprasellar PNET

🔹 Summary Table:
Investigation Purpose

Fundus under EUA Direct visualization of tumor

B-scan USG Detects intraocular mass, calcification

 MRI orbit + brain Optic nerve/brain/pineal involvement

CT scan Calcification (avoid in bilateral cases)

Genetic testing RB1 mutation, family screening

LP/Bone marrow If extraocular spread suspected

To rule out the differential diagnoses (D/Ds) of leukocoria and confirm Retinoblastoma, you
must use a combination of clinical findings, imaging, and key distinguishing features.

Here's a brief comparison and how to rule them out one by one:

🔍 Leukocoria D/Ds & How to Rule Them Out

D/D Age & Key How to Rule
Presentation Differentiatin Out
g Features

1. Congenital At birth or White Slit lamp: lens

Cataract infancy pupillary opacity; Clear
reflex but no B-scan; No
mass on calcification
fundus

2. Coats Males, 5–10 Unilateral; Fundus: “Light

Disease yrs Subretinal bulb” vessels;
exudates & B-scan: No
telangiectasia calcification

3. Persistent Unilateral; Leukocoria + U/S: no

Fetal microphthalmi elongated calcification;
Vasculature a ciliary posterior lens
(PHPV) processes, capsule pulled
 retrolental
membrane

4. Premature, Bilateral History of

Retinopathy low-birth leukocoria prematurity +
of weight infant with dilated fundus
Prematurity peripheral shows
(ROP) retinal avascular
detachment retina

5. 5–10 yrs; Endophthalmit Eosinophilia;

Toxocariasis unilateral is-like signs; ELISA for
retinal Toxocara; no
granuloma calcification

6. Norrie Bilateral, Similar to Family

Disease boys; genetic PHPV + history;
mental genetic
retardation/he testing (NDP
aring loss gene)

7. Coloboma Since birth White reflex Fundus:

(optic disc or due to sharply
retina) chorioretinal demarcated
defect defect; no
mass

🔑 How to Rule IN Retinoblastoma:

●​ Age: Common before 5 years
●​ B-scan ultrasonography: Shows intraocular mass with calcification
●​ MRI: Mass with optic nerve involvement ± trilateral tumors
●​ Fundus under anesthesia: Creamy white vascular mass with seeds
●​ No signs of infection/inflammation as seen in Toxocariasis
 🩺 Clinical Strategy:
1.​ History: Prematurity → ROP; Trauma → Cataract; Family history → Hereditary
retinoblastoma
2.​ Ocular exam: Clear lens? Any vascular abnormality?
3.​ Fundus view: Mass with/without seeding vs exudation vs detachment
4.​ Imaging:
○​ Calcification = Suggestive of Retinoblastoma
○​ No calcification, but membrane or stalk = PHPV
○​ No mass, but cataract = Congenital cataract